The Swiss Glucose Variability Study
The purpose of this study is to explore long term glucose variability of a combination therapy of metformin and vildagliptin compared to a metformin - gliclazide combination.
Multicenter, randomized, open, parallel group, Phase IV study, of 18 months duration.
- Trial with medicinal product
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||The Swiss Glucose Variability Study|
- Mean amplitude of glycemic excursion as described by Service et al. (1970) calculated from the glucose excursions of the CGMS profiles using MiniMedSolution Software (MedtronicMiniMed). [ Time Frame: 48h ] [ Designated as safety issue: No ]
|Study Start Date:||April 2011|
|Estimated Study Completion Date:||January 2013|
|Estimated Primary Completion Date:||January 2013 (Final data collection date for primary outcome measure)|
|Contact: 01 Studienregister MasterAdmins||+41 (0)44 255 11 11|
|Study Director:||01 Studienregister MasterAdmins||UniversitaetsSpital Zuerich|